871 related articles for article (PubMed ID: 15178708)
21. Expression and function of CXC and CC chemokines in human malignant liver tumors: a role for human monokine induced by gamma-interferon in lymphocyte recruitment to hepatocellular carcinoma.
Yoong KF; Afford SC; Jones R; Aujla P; Qin S; Price K; Hubscher SG; Adams DH
Hepatology; 1999 Jul; 30(1):100-11. PubMed ID: 10385645
[TBL] [Abstract][Full Text] [Related]
22. Isolated human astrocytes are not susceptible to infection by M- and T-tropic HIV-1 strains despite functional expression of the chemokine receptors CCR5 and CXCR4.
Boutet A; Salim H; Taoufik Y; Lledo PM; Vincent JD; Delfraissy JF; Tardieu M
Glia; 2001 May; 34(3):165-77. PubMed ID: 11329179
[TBL] [Abstract][Full Text] [Related]
23. Dipeptidyl peptidase IV (CD26) on T cells cleaves the CXC chemokine CXCL11 (I-TAC) and abolishes the stimulating but not the desensitizing potential of the chemokine.
Ludwig A; Schiemann F; Mentlein R; Lindner B; Brandt E
J Leukoc Biol; 2002 Jul; 72(1):183-91. PubMed ID: 12101279
[TBL] [Abstract][Full Text] [Related]
24. CK beta-11/macrophage inflammatory protein-3 beta/EBI1-ligand chemokine is an efficacious chemoattractant for T and B cells.
Kim CH; Pelus LM; White JR; Applebaum E; Johanson K; Broxmeyer HE
J Immunol; 1998 Mar; 160(5):2418-24. PubMed ID: 9498785
[TBL] [Abstract][Full Text] [Related]
25. CCR5 chemokine receptor mediates recruitment of MHC class II-positive Langerhans cells in the mouse corneal epithelium.
Yamagami S; Hamrah P; Miyamoto K; Miyazaki D; Dekaris I; Dawson T; Lu B; Gerard C; Dana MR
Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1201-7. PubMed ID: 15790880
[TBL] [Abstract][Full Text] [Related]
26. STCP-1 (MDC) CC chemokine acts specifically on chronically activated Th2 lymphocytes and is produced by monocytes on stimulation with Th2 cytokines IL-4 and IL-13.
Andrew DP; Chang MS; McNinch J; Wathen ST; Rihanek M; Tseng J; Spellberg JP; Elias CG
J Immunol; 1998 Nov; 161(9):5027-38. PubMed ID: 9794440
[TBL] [Abstract][Full Text] [Related]
27. MIP-1alpha, MIP-1beta, RANTES, and ATAC/lymphotactin function together with IFN-gamma as type 1 cytokines.
Dorner BG; Scheffold A; Rolph MS; Huser MB; Kaufmann SH; Radbruch A; Flesch IE; Kroczek RA
Proc Natl Acad Sci U S A; 2002 Apr; 99(9):6181-6. PubMed ID: 11972057
[TBL] [Abstract][Full Text] [Related]
28. Chemokine receptor 5 and its ligands in the immune response to murine tuberculosis.
Badewa AP; Quinton LJ; Shellito JE; Mason CM
Tuberculosis (Edinb); 2005 May; 85(3):185-95. PubMed ID: 15850756
[TBL] [Abstract][Full Text] [Related]
29. Analysis of second messenger pathways stimulated by different chemokines acting at the chemokine receptor CCR5.
Leach K; Charlton SJ; Strange PG
Biochem Pharmacol; 2007 Sep; 74(6):881-90. PubMed ID: 17645873
[TBL] [Abstract][Full Text] [Related]
30. Pharmacological characterization of the chemokine receptor, CCR5.
Mueller A; Mahmoud NG; Goedecke MC; McKeating JA; Strange PG
Br J Pharmacol; 2002 Feb; 135(4):1033-43. PubMed ID: 11861332
[TBL] [Abstract][Full Text] [Related]
31. Increased responsiveness of murine eosinophils to MIP-1beta (CCL4) and TCA-3 (CCL1) is mediated by their specific receptors, CCR5 and CCR8.
Oliveira SH; Lira S; Martinez-A C; Wiekowski M; Sullivan L; Lukacs NW
J Leukoc Biol; 2002 Jun; 71(6):1019-25. PubMed ID: 12050188
[TBL] [Abstract][Full Text] [Related]
32. Synergistic induction of CXCL9 and CXCL11 by Toll-like receptor ligands and interferon-gamma in fibroblasts correlates with elevated levels of CXCR3 ligands in septic arthritis synovial fluids.
Proost P; Verpoest S; Van de Borne K; Schutyser E; Struyf S; Put W; Ronsse I; Grillet B; Opdenakker G; Van Damme J
J Leukoc Biol; 2004 May; 75(5):777-84. PubMed ID: 14996826
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of respiratory syncytial virus infection with the CC chemokine RANTES (CCL5).
Elliott MB; Tebbey PW; Pryharski KS; Scheuer CA; Laughlin TS; Hancock GE
J Med Virol; 2004 Jun; 73(2):300-8. PubMed ID: 15122808
[TBL] [Abstract][Full Text] [Related]
34. Characterization of the signal transduction pathway activated in human monocytes and dendritic cells by MPIF-1, a specific ligand for CC chemokine receptor 1.
Nardelli B; Tiffany HL; Bong GW; Yourey PA; Morahan DK; Li Y; Murphy PM; Alderson RF
J Immunol; 1999 Jan; 162(1):435-44. PubMed ID: 9886417
[TBL] [Abstract][Full Text] [Related]
35. CCL3 (MIP-1alpha) induces in vitro migration of GM-CSF-primed human neutrophils via CCR5-dependent activation of ERK 1/2.
Ottonello L; Montecucco F; Bertolotto M; Arduino N; Mancini M; Corcione A; Pistoia V; Dallegri F
Cell Signal; 2005 Mar; 17(3):355-63. PubMed ID: 15567066
[TBL] [Abstract][Full Text] [Related]
36. MIP-1alpha[CCL3] acting on the CCR1 receptor mediates neutrophil migration in immune inflammation via sequential release of TNF-alpha and LTB4.
Ramos CD; Canetti C; Souto JT; Silva JS; Hogaboam CM; Ferreira SH; Cunha FQ
J Leukoc Biol; 2005 Jul; 78(1):167-77. PubMed ID: 15831559
[TBL] [Abstract][Full Text] [Related]
37. Chemokines and receptors in HIV encephalitis.
Sanders VJ; Pittman CA; White MG; Wang G; Wiley CA; Achim CL
AIDS; 1998 Jun; 12(9):1021-6. PubMed ID: 9662198
[TBL] [Abstract][Full Text] [Related]
38. Critical role for monocyte chemoattractant protein-1 and macrophage inflammatory protein-1alpha in induction of experimental autoimmune myocarditis and effective anti-monocyte chemoattractant protein-1 gene therapy.
Göser S; Ottl R; Brodner A; Dengler TJ; Torzewski J; Egashira K; Rose NR; Katus HA; Kaya Z
Circulation; 2005 Nov; 112(22):3400-7. PubMed ID: 16316965
[TBL] [Abstract][Full Text] [Related]
39. Differential intracellular expression of CCR5 and chemokines in multiple sclerosis subtypes.
Jalonen TO; Pulkkinen K; Ukkonen M; Saarela M; Elovaara I
J Neurol; 2002 May; 249(5):576-83. PubMed ID: 12021948
[TBL] [Abstract][Full Text] [Related]
40. Differential sensitivities of pyrogenic chemokine fevers to CC chemokine receptor 5 antibodies.
Tavares E; Miñano FJ
Fundam Clin Pharmacol; 2004 Apr; 18(2):163-9. PubMed ID: 15066130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
